Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koji Shinkai

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Ryoikibetsu Shokogun Shirizu|July 25, 2003
[Premonitory depression]Koji Shinkai, Jun Nakamura
Psychiatry and Clinical Neurosciences|May 31, 2006
Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levelsReiji Yoshimura, Sachiko Kaneko, Koji Shinkai, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 28, 2004
Clinical response to antidepressant treatment and 3-methoxy-4-hydroxyphenylglycol levels: mini reviewReiji Yoshimura, Jun Nakamura, Koji Shinkai, et al.
International Clinical Psychopharmacology|February 25, 2003
Plasma levels of homovanillic acid and the response to risperidone in first episode untreated acute schizophreniaReiji Yoshimura, Nobuhisa Ueda, Koji Shinkai, et al.
Journal of Clinical Psychopharmacology|January 8, 2004
Associations between baseline plasma MHPG (3-methoxy-4-hydroxyphenylglycol) levels and clinical responses with respect to milnacipran versus paroxetine treatmentKoji Shinkai, Reiji Yoshimura, Nobuhisa Ueda, et al.
Neuropsychobiology|July 30, 2003
Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nauseaNobuhisa Ueda, Reiji Yoshimura, Koji Shinkai, et al.
Human Psychopharmacology|September 15, 2005
Effects of zotepine and olanzapine on noradrenaline transporter in cultured bovine adrenal medullary cellsReiji Yoshimura, Koji Shinkai, Yumiko Toyohira, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 11, 2007
Stimulation of catecholamine synthesis via activation of p44/42 MAPK in cultured bovine adrenal medullary cells by milnacipranKoji Shinkai, Yumiko Toyohira, Reiji Yoshimura, et al.
Biochemical Pharmacology|September 13, 2005
Effect of prolonged exposure to milnacipran on norepinephrine transporter in cultured bovine adrenal medullary cellsKoji Shinkai, Reiji Yoshimura, Yumiko Toyohira, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 4, 2006
Risperidone in the treatment of psychotic depressionMakiko Goto, Reiji Yoshimura, Shingo Kakihara, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Ryoikibetsu Shokogun Shirizu|July 25, 2003
[Premonitory depression]Koji Shinkai, Jun Nakamura
Psychiatry and Clinical Neurosciences|May 31, 2006
Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levelsReiji Yoshimura, Sachiko Kaneko, Koji Shinkai, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 28, 2004
Clinical response to antidepressant treatment and 3-methoxy-4-hydroxyphenylglycol levels: mini reviewReiji Yoshimura, Jun Nakamura, Koji Shinkai, et al.
International Clinical Psychopharmacology|February 25, 2003
Plasma levels of homovanillic acid and the response to risperidone in first episode untreated acute schizophreniaReiji Yoshimura, Nobuhisa Ueda, Koji Shinkai, et al.
Journal of Clinical Psychopharmacology|January 8, 2004
Associations between baseline plasma MHPG (3-methoxy-4-hydroxyphenylglycol) levels and clinical responses with respect to milnacipran versus paroxetine treatmentKoji Shinkai, Reiji Yoshimura, Nobuhisa Ueda, et al.
Neuropsychobiology|July 30, 2003
Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nauseaNobuhisa Ueda, Reiji Yoshimura, Koji Shinkai, et al.
Human Psychopharmacology|September 15, 2005
Effects of zotepine and olanzapine on noradrenaline transporter in cultured bovine adrenal medullary cellsReiji Yoshimura, Koji Shinkai, Yumiko Toyohira, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 11, 2007
Stimulation of catecholamine synthesis via activation of p44/42 MAPK in cultured bovine adrenal medullary cells by milnacipranKoji Shinkai, Yumiko Toyohira, Reiji Yoshimura, et al.
Biochemical Pharmacology|September 13, 2005
Effect of prolonged exposure to milnacipran on norepinephrine transporter in cultured bovine adrenal medullary cellsKoji Shinkai, Reiji Yoshimura, Yumiko Toyohira, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 4, 2006
Risperidone in the treatment of psychotic depressionMakiko Goto, Reiji Yoshimura, Shingo Kakihara, et al.
Pageof 2